| Literature DB >> 25544839 |
Abdulrahman K Al-Asmari1, R Abbasmanthiri1, Abdulrahman M Al-Elewi2, Saud Al-Omani3, Saeed Al-Asmary4, Sarah A Al-Asmari5.
Abstract
The potential effect of camel milk (CM) against gentamicin (GM) induced biochemical changes in the rat serum was evaluated. Four groups of six albino rats were used for control, CM fed, injected with GM(i.p.), and then fed and injected with GM. The results showed that the administration of GM significantly altered the levels of aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) activity in rat serum. CM restored these parameters to almost their normal range in group IV. Additionally, the present study showed that injection of rats with gentamicin caused an increase in malondialdehyde (MDA) and myeloperoxidase (MPO) activity while the antioxidant enzymes like superoxide dismutase (SOD) and glutathione s-transferase (GST) activity decreased significantly (P ≤ 0.05). Administration of CM significantly (P ≤ 0.05) inhibited the formation of MDA and activity of MPO and upregulated the antioxidant enzymes (SOD and GST) activity. The overall findings of this study demonstrated that pretreatment with CM gave protection against GM induced hepatic damage possibly by inhibiting oxidative stress and inflammation, and hence camel milk can be identified as a new therapeutic agent.Entities:
Year: 2014 PMID: 25544839 PMCID: PMC4269313 DOI: 10.1155/2014/917608
Source DB: PubMed Journal: J Toxicol ISSN: 1687-8191
Effect of camel milk on the activity of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphate (ALP), and lactate dehydrogenase (LDH).
| Parameters | Group I | Group II | Group III | Group IV |
|---|---|---|---|---|
| ALT (U/L) | 29.15 ± 1.85 | 31.65 ± 0.90 | 39.70 ± 2.17a | 33.62 ± 3.0b |
| AST (U/L) | 77.08 ± 2.5 | 68.37 ± 3.53d | 128.63 ± 6.31a | 111.02 ± 5.25a,b,c |
| ALP (U/L) | 58.80 ± 6.90 | 77.07 ± 10.75d | 123.29 ± 9.09a | 87.29 ± 5.96a,b,c |
| LDH (U/L) | 332.89 ± 17.59 | 212.04 ± 17.80d | 466.93 ± 15.54a | 398.81 ± 15.76a,b,c |
Values are given as means ± SEM for groups of six animals each. Values are statistically significant between two groups P ≤ 0.05. aControl group compared with gentamicin group; bcontrol groups compared with camel milk and gentamicin group; cgentamicin groups compared with camel milk and gentamicin group; dcontrol groups compared with camel milk group.
Figure 1Effect of camel milk and gentamicin on lipid peroxidation. Effect of CM administration on GM induced renal lipid peroxidation. Values are expressed as mean ± SEM (n = 6). *** P < 0.001 shows significant difference in group III when compared with group I. # P < 0.05 shows significant difference in group IV when compared with group III.
Figure 2Effect of camel milk and gentamicin on SOD enzymes. Effect of CM intake and GM on renal SOD activity. Values are expressed as mean ± SEM (n = 6). ** P < 0.01 shows significant difference in group III when compared with group I. # P < 0.01 shows significant difference in group IV when compared with group III.
Figure 3Effect of camel milk and gentamicin on GST enzymes. Effect of CM treatment on GM induced renal GST activity. Values are expressed as mean ± SEM (n = 6). *** P < 0.001 shows significant difference in group III when compared with group I. # P < 0.05 shows significant difference in group IV when compared with group III.
Figure 4Effect of camel milk and gentamicin on myeloperoxidase activity. Effect of CM administration on GM induced renal MPO activity. Values are expressed as mean ± SEM (n = 6). ** P < 0.01 shows significant difference in group III when compared with group I. # P < 0.05 shows significant difference in group IV when compared with group III.